Novartis's Alcon unit has signed a deal with Google to license the latter's "smart lens" technology, which could lead to medical innovations such as constant blood sugar monitoring via the eye, or adaptive focusing of contact lenses.
Google said back in January that it was looking for a partner to bring to market its smart contact lens. The new deal sees Alcon obtain rights to the technology...